Hand-out
Press Releases
Caliway Completed CBL-514 Phase 2b Study (CBL-0205) for Subcutaneous Fat Reduction
The first and only lipolytic injectable for large area – CBL-514's last Phase 2b study has been completedBoth CBL-514 Phase 2b studies used efficacy assessment tools, AFRS and MRI, in
